These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 959773)

  • 41. Thrombocytosis and thrombocythemia: qualitative platelet abnormalities.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1265-72. PubMed ID: 2629455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
    Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
    Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Changes in platelet functions and blood coagulation in patients with bronchopulmonary cancer].
    Cutcudache C; Popescu I; Boldescu G; Antal C; Păunescu R; Pleşea I; Cojocea D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(4):357-68. PubMed ID: 2879340
    [No Abstract]   [Full Text] [Related]  

  • 44. [Platelet aggregation, circulating platelet aggregates and heparin-thrombin time in acute myocardial infarct].
    Florkiewicz H; Pluta A; Koziara Z; Markiewicz M; Kowalewski J; Dmoszyńska A; Szponar M
    Pol Tyg Lek; 1980 Dec; 35(48):1845-7. PubMed ID: 7208389
    [No Abstract]   [Full Text] [Related]  

  • 45. [Plasma beta-thromboglobulin level in thromboembolic diseases: a marker of in-vivo platelet release reaction].
    Modiano A
    G Clin Med; 1980 Sep; 61(9):672-8. PubMed ID: 6162700
    [No Abstract]   [Full Text] [Related]  

  • 46. The importance of blood collection methods for assessment of platelet activation.
    Levine SP; Suarez AJ; Sorenson RR; Knieriem LK; Raymond NM
    Thromb Res; 1981 Dec 1-15; 24(5-6):433-43. PubMed ID: 7344171
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T; Tamura Y; Fukuda N; Ito S
    Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet disorders: an overview.
    Krishnegowda M; Rajashekaraiah V
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):479-91. PubMed ID: 26126029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Assessment of platelet factor IV for the evaluation of platelet function in patients with ischemic cardiopathy].
    de Teresa E; Lorenz MP; Vera A; Ortigosa J; Chamorro JL; de Artaza M
    Rev Esp Cardiol; 1981; 34(4):311-5. PubMed ID: 7323384
    [No Abstract]   [Full Text] [Related]  

  • 50. An improved procedure for quantitation of platelet factor 4.
    Saleem A; Fretz K
    Am J Clin Pathol; 1977 Jun; 67(6):533-6. PubMed ID: 868792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet function in patients with high platelet counts.
    Ginsburg AD
    Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma heparin neutralizing activity in patients with valvular stenosis and prosthetic heart valves.
    Dana B; Ellman L; Carvalho A; Daggett WM
    J Cardiovasc Surg (Torino); 1977; 18(1):29-34. PubMed ID: 833188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormalities in platelet function and morphology in a case of thrombocythemia.
    Ts'ao CH; Rossi EC; Lestina FC
    Arch Pathol Lab Med; 1977 Oct; 101(10):526-33. PubMed ID: 578684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Determination of platelest factor III. (Total content and availability)].
    Scrobohaci ML
    Med Interna (Bucur); 1974 May; 26(5):623-32. PubMed ID: 4526294
    [No Abstract]   [Full Text] [Related]  

  • 55. The assessment of platelet function in vivo by measurement of beta-thromboglobulin, platelet factor 4 and platelet survival.
    Ludlam CA
    Artery; 1980; 8(5):470-4. PubMed ID: 6163418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 57. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.
    Appiani AC; Edefonti A; Bettinelli A; Cossu MM; Paracchini ML; Rossi E
    Clin Nephrol; 1982 Apr; 17(4):195-9. PubMed ID: 6176380
    [No Abstract]   [Full Text] [Related]  

  • 58. [Plasma levels of beta-thromboglobulin and platelet factor 4 in clinical conditions (author's transl)].
    Motomiya T; Yahara Y; Onozawa Y; Watanabe C; Tomura S; Sano T; Yamazaki H
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):864-70. PubMed ID: 6165212
    [No Abstract]   [Full Text] [Related]  

  • 59. Subcellular localization of the heparin-neutralizing factor in blood platelets.
    Da Prada M; Jakábová M; Lüscher EF; Pletscher A; Richards JG
    J Physiol; 1976 May; 257(2):495-502. PubMed ID: 950602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of platelet activation products (platelet factor IV and beta-thromboglobulin) in a group of workers with long-term exposure to carbon disulfide].
    Craveri A; Lanfredini M; Tornaghi G; Frangione A; Milella AM; Ranieri R; Tonali M; Gatti L; Franco G; Moia M
    G Clin Med; 1980 Nov; 61(11):812-21. PubMed ID: 6165639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.